The influence of Radloff-Intervention on disability and cortical representation in chronic non-specific low-back-pain. A single-subject-design study.

The influence of Radloff-Intervention on disability and cortical representation in chronic non-specific low-back-pain. A single-subject-design study. - RadES

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006195

Enrollment

Registered

2014-11-06

Start date

2014-11-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M54.5

Interventions

Group 1: A single-subject design with A1-B-A2 –alternating phases is used. The baseline period (A1) lasts four weeks. During this phase baseline measures are collected twice a week, making a total of

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Reffered by physician, chronic non-specific low back pain, adequat knowledge of German language, Informed consent.

Exclusion criteria

Exclusion criteria: Specific low back pain, serious neurologic or systemic illness, previous back surgery, Osteoporosis, high-risk pregnancy, Fear-Avoidance Believe Questionnaire-Score >28, Roland-Morris Disability Questionnaire-Score <5, use of neuroleptica/Anti-Depressiva/Sedativa or Anti-Epileptica, other therapyinterventions (except oral NSAID)

Design outcomes

Primary

Measure	Time frame
The patient-specific functional scale, VAS (0-100). Assessment: A1-phase: 2/week during 4 weeks; B-phase: before treatment; A2-phase: 1/week, during 4 weeks.	—

Secondary

Measure	Time frame
1) Disability caused by LBP, Roland-Morris disability questionnaire (RMDQ-D), Assessment: A1-B-A2-phase: 1/week . 2) Generall and actuell painintensity, VAS (0-100), Assessment: A1-phase: 2/week during 4 weeks; B-phase: before treatment; A2-phase: 1/week, during 4 weeks. 3) Finger-to-floor test (cm), Assessment: A1-phase: 2/week during 4 weeks; B-phase: before treatment; A2-phase: 1/week, during 4 weeks. 4) Two-point discrimination test (cm), Assessment: A1-phase: 2/week during 4 weeks; B-phase: before and after each treatment; A2-phase: 1/week, during 4 weeks.	—

Measure

Time frame

1) Disability caused by LBP, Roland-Morris disability questionnaire (RMDQ-D), Assessment: A1-B-A2-phase: 1/week . 2) Generall and actuell painintensity, VAS (0-100), Assessment: A1-phase: 2/week during 4 weeks; B-phase: before treatment; A2-phase: 1/week, during 4 weeks. 3) Finger-to-floor test (cm), Assessment: A1-phase: 2/week during 4 weeks; B-phase: before treatment; A2-phase: 1/week, during 4 weeks. 4) Two-point discrimination test (cm), Assessment: A1-phase: 2/week during 4 weeks; B-phase: before and after each treatment; A2-phase: 1/week, during 4 weeks.

—

Countries

Switzerland

Contacts

Public ContactJoannes Raijmakers

Physiotherapie "Bel-Air"

raijmjoa@students.zhaw.ch(0041) (0)44 7250681

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026